Westhampton Capital’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.84M Hold
2,367
1.18% 23
2026
Q1
$2.18M Sell
2,367
-25
-1% -$25.3K 1.02% 25
2025
Q4
$2.57M Sell
2,392
-50
-2% -$47.8K 1.21% 20
2025
Q3
$1.86M Hold
2,442
0.91% 34
2025
Q2
$1.9M Buy
2,442
+343
+16% +$267K 0.98% 31
2025
Q1
$1.73M Hold
2,099
0.95% 33
2024
Q4
$1.62M Buy
2,099
+10
+0.5% +$8.28K 0.83% 41
2024
Q3
$1.85M Sell
2,089
-135
-6% -$121K 0.94% 36
2024
Q2
$2.01M Sell
2,224
-25
-1% -$20K 1.09% 25
2024
Q1
$1.75M Sell
2,249
-10
-0.4% -$7.12K 0.96% 33
2023
Q4
$1.32M Sell
2,259
-7
-0.3% -$4.09K 0.78% 48
2023
Q3
$1.22M Buy
+2,266
New +$1.17M 0.78% 46
2023
Q2
Sell
-2,259
Closed -$776K 120
2023
Q1
$776K Hold
2,259
0.5% 61
2022
Q4
$826K Sell
2,259
-10
-0.4% -$3.55K 0.56% 59
2022
Q3
$734K Hold
2,269
0.55% 59
2022
Q2
$736K Hold
2,269
0.52% 62
2022
Q1
$650K Buy
2,269
+40
+2% +$10.3K 0.42% 71
2021
Q4
$616K Hold
2,229
0.38% 74
2021
Q3
$515K Sell
2,229
-300
-12% -$74K 0.35% 80
2021
Q2
$580K Buy
2,529
+810
+47% +$163K 0.38% 74
2021
Q1
$321K Buy
+1,719
New +$336K 0.22% 96

Other funds holding LLY

Westhampton Capital's LLY Position: Q2 2026 in Review

Westhampton Capital held its Eli Lilly (LLY) position steady in Q2 2026 at 2,367 shares worth $2.84M. The position accounts for 1.18% of the portfolio, ranked #23.

Westhampton Capital first reported a position in LLY in Q1 2021 and has held it in 21 quarters since. 1,691 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Westhampton Capital held 2,367 shares of Eli Lilly worth $2.84M as of Q2 2026.
  • Westhampton Capital left its Eli Lilly share count unchanged in Q2 2026.
  • Eli Lilly made up 1.18% of Westhampton Capital's portfolio in Q2 2026, its #23 holding.
  • Westhampton Capital first reported a position in Eli Lilly in Q1 2021 and has held it in 21 quarters since.
  • 1,691 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Westhampton Capital's 13F filing for Q2 2026, filed 14 Jul 2026.